As shown in Table 2, the plasma levels of sCD40L, sTNFRII, sIL-6R, AFP, ANGPTL4, CXCL1, HGF, sEGFR, and sgp130 early during SBRT were not associated with in-field tumor response at 3 months after completion of SBRT. The gene discussed is IL6R; the disease is neoplasm.